Agincourt Bio Consulting is a global life science consulting firm that specializes in facilitating strategic partnerships and alliances between companies in Western markets and Asia. They help clients identify partnership and licensing opportunities, evaluate clinical assets, structure deals, and access investors and capital. Their proprietary partnering methodology focuses on identifying high-value alliance opportunities by screening therapeutic projects and accessing clinical asset data.

1. “ Agincourt takes the hard work
& confusion out of identifying
licensing targets & structuring
alliances.
We can evaluate relevant
therapeutic & strategically
aligned projects & access
clinical asset data directly
which simplifies and speeds up
the due diligence process’”
- Asian Pharma focused on
evaluating Oncology compounds
What We Do
 Identify Partnerships
 Create Linkages
 Structure Deals
 Advise on Strategy
 Access Capital
 Unlock Investment
 IP Commercialisation
About Us
Agincourt Bio Consulting is a global life science & healthcare consultancy
specializing in strategic planning, commercialisation services, partnership
program identification and strategic alliance mapping and management.
Our core business is facilitating cross border partnering between Western
pharma and Asia companies , taking advantage of the current IP appetite
& technology transfer opportunities.
With 20 years operational experience in the healthcare, life sciences,
pharmaceutical & medical device sectors we help our clients identify &
manage strategic partnership alliances, engage and execute licensing
agreements, access investor networks & capital, monetize assets &
commercialise IP.
Agincourt Bio Consulting has developed a proprietary strategic partnering
methodology called Smart Partnering, which focuses on identifying high
value target alliance opportunities.
We work with Life Science, Biotech, Tier 1 Pharma, Medical Device &
Diagnostic clients and have built an industry network database of over
100,000 unique, pre qualified contacts with an identified interested in
licensing, partnering and investment opportunities.
Strategic Partnering Services Reach Our ReachUnique
Partner Identification Commercialisation Investor Networks Strategic Alliances
Reach Our Unique Industry Network
www.agincourtbioconsulting.com 1

2. OUR SERVICES
We specialize in cross border licensing, co-development and joint venture
engagements taking advantage of the current IP appetite from Asian markets and
the emergence of innovative Asian IP seeking partners in the west.
We work with you to identify your ideal investment framework and seek to provide
exposure to the right financial vehicles.
We can advise firms looking to in licensing, acquire or out license clinical products,
platforms, programs, devices or technology and can assist in assessing these
candidates for commercial potential and internal strategic portfolio synergies.
Our business is centred around value creation for our clients who reside on both
sides of the buyer / seller equation. This means we often act as an independent
intermediary and communication facilitator during the due diligence process and
beyond.
We use our experience in complex, high level, multi culture centred negotiations to
keep a deal on track and avoid it languishing in deadlock. Often understanding the
other side’s point of view, without emotional attachment to an asset, can lead to a
swift & mutually beneficial resolution of a potential issue.
OUR BACKGROUND
Having worked with hundreds of global Pharmaceutical, Biotech and Medical
Device entities we have advised companies, leadership teams, industry bodies &
organizations on corporate development, strategic planning, product and portfolio
rationalization / diversification, opportunity assessment, market sizing, product
launch and market entry strategies, deal structure support, technology validation,
transaction decisions and term sheet discussions.
We have a deep understanding of market data, research, forecasting and analysis
and how these tools can be used in a pragmatic way to create valuation models,
where realizing and agreeing realistic expectations is the essential first step in
developing an appropriate negotiation strategy.
We leverage our commercial relationships with our global network utilizing our
proprietary Strategic, Tactical & Operational Partnering methodology to deliver a
market driven partnering and commercialisation approach.
Our Values as a
business
Our values & ethics are core to the
projects we engage in. We adhere
to a strict code of conduct that is
aligned to industry best practices,
client compliance & regulatory
directives & anti bribery provisions.
Our position on corporate integrity
is very simple:
"There is no value in a deal
unless there is a win win for
both parties"
www.agincourtbioconsulting.com
5 Top Reasons Why You Need A China Strategy
2nd Largest
pharmaceutical
market in the world
and growing
Healthcare spending
forecast to reach one
trillion USD by 2020
Partnering most
advisable market
entry strategy
400 China
partnering deals in
the last 5 years
Healthcare Reforms
Pricing &
Reimbursement
Regulatory
Environment
Average
deal size
in 2014
$50m
www.agincourtbioconsulting.com 2

3. Key
Partnering
Drivers
Based on primary research we
have identified the following
drivers as being the most
influential when licensing assets:
 Supporting Science
 Commercial Relevance
 Valuation
 Business / Commercial
Strategy & Internal Cultural
Synergies
Identify Strategic Partners
Survey Data Indicates Primary Investment Sectors of Interest
2015 Agincourt Bio Consulting Investor Sector Survey Results
Partnering Sectors of Interest
We survey our database of investors and buy side entities to identify key areas
where they are seeking alliance opportunities. We know what areas are important to
our investors and licensors and we then match and present relevant opportunities.
Investment sectors of interest include:
 Therapeutic Area
 Indication
 Devices
 Diagnostics
 Technologies
www.agincourtbioconsulting.com
3

4. Targeted Life Science Partnering Solutions
 Targeted exposure to a global community of Life Science, Biotech,
Pharmaceutical, Healthcare and Medical device companies.
 Strategic engagement channel via our database of over 100,000 individual
contacts across the global industry sector.
 Value message timely & dynamic company , milestone & product updates.
Company & Product Showcase
Featured as part of our corporate website, which is the gateway to investment asset
review for our clients, we host a dedicated Investment Portfolio Portal.
This is an interactive touch point that we think of as a one stop partnering shop..
where we show case clinical products, technologies, devices & companies.
Interested parties can request more information and even exchange contracts
and enter into a due diligence engage-ment, via a pre loaded data room, directly
from our website.
Featuring:
 Corporate Logo
 Company Overview / Capability Statement
 Link to your Corporate Website / Brochure / Product Collateral
 Link to an Educational Article, White Paper, Corporate experiance overview,
Value Statement, Educational / Scientific Presentation etc.
“If you are interested in
Strategic Alliances,
Licensing, Acquisition,
Joint Ventures, Raising
Capital, Expanding your
Investor Network or have
IP you would like to
Commercialize...
we would like to hear
from you”
Effectively Address Your Market
Target The Right Partners, With The Right Message, At The Right Time
Leverage our unique direct
to Industry communication
capability to establish your
partnering profile
www.agincourtbioconsulting.com 4

5. Successful Partnership
Programs
When it comes to business
strategy we can help.
Utilizing our networks we
create linkages, facilitate
introductions with future
partners and align
commercially relevant
projects with the right
teams to forge strategic
alliances.
Client Engagement
We provide a unique
platform for companies to
increase their exposure
through leveraging a direct
voice to industry approach.
Your platform,
getting your message
across
Because we know that
every asset is unique its
important to educate
Investors and partners with
the right mix between
supporting science &
commercial content.
As a client your company
will gain second to none
exposure to those
executives & decision
makers at the point in time
that they are seeking
products, information and
solutions for their strategic
partnering programs.
Provide The Market With Timely & Dynamic Investment Updates
Key Investment Portfolio Profile Advantages
Reach A New Audience:
Establish essential new relationships by reaching & connecting with a wider industry pool of
partners, investors & the people you need to know and do business with moving forward.
Develop Product or Company Awareness:
Ensure meaningful market driven interactions delivering high impact awareness.
Educate Industry & Influence Partnership Engagement:
By providing access to data or highlighting clinical milestones you can showcase your
Science and influence interest & engagement behavior targeting decision makers
through a scientific or tactical presentation.
Industry Survey:
We survey our database and analyze the results to ensure we are on trend with meeting
hot industry partnering interests. The Survey delivers the insight needed to strategically
target your investor base. Learn about their licensing patterns, plans and more.
Capability Demonstration/Announcement:
Launch or showcase your science or technology offerings directly to influencers and
investors. Show how instrumental your IP is to solving a range of unmet market issues.
Drive Traffic to Your Website:
Via content links to further highlight product details.
www.agincourtbioconsulting.com 5

6. Value Messaging
Agincourt Bio Consulting
can help you strategically
engage with prospective
partners.
We can identify the right
companies to target and
align mutual business,
commercial and cultural
synergies.
Deliver value to your
strategic alliance &
partnership programs by
understanding the buy
side and referencing
appropriate material in
your IP value dossier.
We identify and screen
potential investors and
partners based on buy
side requirements ,
profiling companies which
reflect the markets'
needs.
This is why we are able
to consistently execute
win win deals for our
clients.
With a global life sciences
database of over 100,000
unique contacts...
we invite you to engage
with interested & aligned
parties.
Highlight Your Company, Product & Innovation To Our Investment Community
Custom Business Development Services
We provide a pro active approach when presenting your asset to a potential partner.
We present onsite in local language to identified high value targets and then gauge,
evaluate & map potential interest and subsequent follow up activities.
This means we do the travelling, we put in the hours on the road and in the board
room so when a potential partner is interested enough to want to meet you it’s a pre
qualified, valuable partnering opportunity.
Your time is precious and we believe you should invest it with care.
So whether its licensing, co development, co marketing, sales, distribution, joint
ventures, partnership frameworks, investment capital, acquisition or trade sale of your
assets we can help develop the right strategy and execute on your behalf.
Talk to us about how we can help support you.
www.agincourtbioconsulting.com 6

7. Lets Meet!
We have over 20
years commercial
experience in the
Healthcare and
Finance sectors
and we have
developed and
nurtured a global
network which
enables us to
facilitate business
transactions for our
clients.
We're always interested
in talking to new
companies &
organizations with
similar values to explore
synergies for business
opportunities.
Focused On Discovering Your Next Strategic Alliance
ENGAGEMENT PLANNING
We can provide guidance around the preparation of your partnering materials,
dataroom structure and process, pre due diligence and or investment preparation
including asset valuation using benchmarking against industry norms, commercial
potential, market opportunity and sizing, GHEOR data, value dossier preparation,
value messaging, competitive landscape, USP, clinical data, supporting science,
IP, product development strategy etc.
Our engagement framework means we remain a committed resource to your
company at all stages of the commercialization journey and we share a committed
focus to realizing the execution of your deal.
PARTNERING
There are many structures available to consider when beginning thinking about
partnering and retaining a flexible and agile approach to capitalizing on emergent
opportunities is essential.
Bring an open mind to the table and be prepared to explore alternative investment
structures and scenarios. Remember the right partner represents much more than
just a short term injection of cash…the cross flow transfer of experience,
expertise, resources, knowledge and funding is what leads to a powerful, mutually
beneficial and sustainable relationship where the jointly committed end goal is to
fast track the development of your clinical program or IP.
www.agincourtbioconsulting.com
7
We look forward to
meeting you and your
team and to helping
you define your goals
and develop solutions.

8. Contact Us
Please call for more
Information about our
services and discover how we
can support your business.
Agincourt Bio Consulting
+61 (2) 6166 7042
+61 (0) 420 393706
info@agincourtbioconsulting.com
Visit us at
www.agincourtbioconsulting.com
Getting it right...First time
Your business strategy and partnership programs are critical to the success of your
venture. You wouldn’t risk running a clinical trial without support so why would you
risk executing commercial partnership agreements without the right advice?
Executing a complex agreement with a new business partner is like preparing for an
IPO or raising capital. It’s time and labour intensive. Once the due diligence process
starts it’s intense and often requires experience, diplomacy and an objective view
point to execute well.
Emotionally invested parties can lead to clouded judgments, unrealistic expectations
and unnecessary hold ups.
Our expertise and experience can turn the situation around and save the deal, paving
the way to an execution of agreement.
Talk to us today to find out how we can work with you to achieve win win business
outcomes.
Access The Asian Market Opportunity
There is a fast closing window to capitalize on partnerships, investment, joint venture
and licensing opportunities from Asian markets experiencing explosive growth or to
evaluate in licensing potential from emerging innovative Asian IP.
We specialize in facilitating cross border partnering and can help road map your Asia
plan.
Value Creation Through Identifying Synergistic Opportunities
www.agincourtbioconsulting.com 8